(0)サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1751541

雑菌済み（RTU）医薬品容器の市場規模、シェア、動向分析レポート：容器タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Ready-to-Use Pharmaceutical Packaging Market Size, Share & Trends Analysis Report By Container Type (Sterile Syringes, Sterile Cartridges), By End Use (Glass, Plastic, Rubber), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.69円
雑菌済み（RTU）医薬品容器の市場規模、シェア、動向分析レポート：容器タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月19日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

雑菌済み（RTU）医薬品容器市場の成長と動向：

Grand View Research, Incの最新レポートによると、世界の雑菌済み（RTU）医薬品容器市場規模は2030年までに156億6,000万米ドルに達すると予測され、予測期間中にCAGR 7.2％で拡大すると予測されています。

雑菌済み（RTU）医薬品容器業界は、世界のヘルスケアと医薬品サプライチェーンの重要な構成要素であり、無菌保証、業務効率、規制遵守を強化する役割で知られています。滅菌済みのバイアル、シリンジ、カートリッジで構成されるRTU容器は、社内での洗浄・滅菌工程を不要にし、製薬メーカーの無菌充填・仕上げ作業の合理化を可能にします。

この市場は、ワクチンや生物製剤からがん治療薬や緊急用注射剤まで、幅広い用途に対応しています。製薬業界が注射療法の世界の需要増に対応するために進化する中、RTU形式は、汚染リスクを低減し、市場投入までの時間を短縮し、分散型の製造ネットワークで一貫した品質を確保する能力で際立っています。雑菌済み（RTU）医薬品容器市場の拡大の主な要因は、厳格な無菌性と包装精度を必要とする生物製剤や高力価医薬品へのシフトが進んでいることです。RTU容器は、労働集約度の低減、滅菌インフラへの設備投資の低減、規制当局による検証の迅速化など、従来の包装形態と比較して製薬企業に大きな利点を提供します。これらの利点は、バイオ医薬品への投資が拡大している地域や、生産の柔軟性が重要なCDMO環境において特に価値があります。

さらに、高粘度生物製剤用ポリマーベースシリンジや先進バリアコートガラスなど、包装材料や容器閉鎖システムの革新が新たな用途を開発し、品質主導、効率重視の製薬業界においてRTU市場の存在感を高めています。市場関係者は合併、買収、提携など様々な戦略的取り組みに注力しています。例えば、2025年3月、Heitkamp &Thumann Groupの一部門であるH&T Presspart社は、生物製剤、モノクローナル抗体、細胞ベースの治療薬などの高度な治療薬向けに設計された革新的なRTUスナップフィットクロージャーであるVytalを発売しました。

雑菌済み（RTU）医薬品容器市場レポートハイライト

  • 容器タイプ別では、無菌バイアルが最大のシェアを占め、2024年の市場規模は51億7,000万米ドル。
  • 最終用途別では、ガラスが2024年に56.12%の最大シェアを占める。
  • 北米が市場を独占。北米のバイオ医薬品企業における無菌製剤のアウトソーシング需要の高まりは、CDMOがスループットを最適化するためにReady-to-fill形式を優先するため、RTU容器の採用を促進しています。この動向は、米国とカナダにおける無菌充填・仕上げ工程の能力拡張によってさらに強化されています。
  • 米国は北米の主要市場であり、2024年の売上高市場シェアの約80%を占めています。
  • エンジニアリングプラスチックのリサイクル市場に参入している企業には、Schott AG、Gerresheimer AG、West Pharmaceutical Services、Stevanato Group、SGD Pharma、Nipro Corporation、AptarGroup、Berry Global、Datwylerなどがあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 雑菌済み（RTU）医薬品容器市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
  • 浸透と成長の見込みマッピング
  • 業界バリューチェーン分析
    • 原材料の動向
  • テクノロジーの概要
    • 商業生産技術
    • 技術進歩のロードマップ、2018年から2030年
  • 循環型経済の影響
  • 規制の枠組み
    • ポリシーとインセンティブプラン
    • 標準とコンプライアンス
    • 規制影響分析
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界の課題
  • ポーターのファイブフォース分析
    • サプライヤーの力
    • 買い手の力
    • 代替の脅威
    • 新規参入からの脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治情勢
    • 経済情勢
    • 社会情勢
    • 技術的情勢
    • 環境情勢
    • 法的な情勢

第4章 雑菌済み（RTU）医薬品容器市場：容器タイプ別推定、予測

  • 雑菌済み（RTU）医薬品容器市場：容器タイプ別変動分析、2024年および2030年
    • 滅菌バイアル
    • 滅菌注射器
    • 滅菌カートリッジ

第5章 雑菌済み（RTU）医薬品容器市場：最終用途別推定、予測

  • 雑菌済み（RTU）医薬品容器市場：最終用途別変動分析、2024年および2030年
    • ガラス
    • プラスチック
    • ゴム
    • アルミニウム

第6章 雑菌済み（RTU）医薬品容器市場の地域別、推定、予測

  • 地域スナップショット
  • 雑菌済み（RTU）医薬品容器市場：地域変動分析、2024年および2030年
  • 北米
    • 市場推計・予測、2018年～2030年
    • 容器タイプ別、2018年～2030年
    • 最終用途別、2018年～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 市場推計・予測、2018年～2030年
    • 容器タイプ別、2018年～2030年
    • 最終用途別、2018年～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋
    • 市場推計・予測、2018年～2030年
    • 容器タイプ別、2018年～2030年
    • 最終用途別、2018年～2030年
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • 市場推計・予測、2018年～2030年
    • 容器タイプ別、2018年～2030年
    • 最終用途別、2018年～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 市場推計・予測、2018年～2030年
    • 容器タイプ別、2018年～2030年
    • 最終用途別、2018年～2030年
    • サウジアラビア
    • 南アフリカ

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • ベンダー情勢
    • 企業分類
    • 主要販売代理店およびチャネルパートナーのリスト
    • 潜在顧客/エンドユーザーのリスト
  • 競争ダイナミクス
    • 企業の市場シェア分析と市場ポジショニング
    • 競合ベンチマーキング
    • 戦略マッピング
    • ヒートマップ分析
  • 企業プロファイル/上場企業
    • 参入企業の概要
    • 財務実績
    • 製品ベンチマーク
      • Schott AG
      • Gerresheimer AG
      • West Pharmaceutical Services
      • Stevanato Group
      • SGD Pharma
      • Nipro Corporation
      • AptarGroup
      • Berry Global
      • Datwyler
図表

List of Tables

  • Table 1. List of Abbreviations
  • Table 2. Type market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 3. Fluorocarbon market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 4. Fluorosilicone market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 5. Perfluoroelastomers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 6. End Use market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 7. Automotive market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 8. Aerospace market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 9. Chemicals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 10. Oil & Gas market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 11. Energy & Power market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 12. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table 13. North America ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 14. North America ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 15. U.S. ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 16. U.S. ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 17. Canada ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 18. Canada ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 19. Mexico ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 20. Mexico ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 21. Europe ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 22. Europe ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 23. Germany ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 24. Germany ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 25. UK ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 26. UK ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 27. France ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 28. France ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 29. Italy ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 30. Italy ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 31. Spain ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 32. Spain ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 35. China ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 36. China ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 37. India ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 38. India ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 39. Japan ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 40. Japan ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 41. South Korea ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 42. South Korea ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 43. Australia ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 44. Australia ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 45. Latin America ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 46. Latin America ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 47. Brazil ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 48. Brazil ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 49. Argentina ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 50. Argentina ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 51. Middle East Africa ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 52. Middle East Africa ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 53. Saudi Arabia ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 54. Saudi Arabia ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • Table 55. South Africa ready-to-use pharmaceutical packaging market estimates and forecasts, by container type, 2018 - 2030 (USD Million)
  • Table 56. South Africa ready-to-use pharmaceutical packaging market estimates and forecasts, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data Analysis Models
  • Fig. 4 Market Formulation and Validation
  • Fig. 5 Market snapshot
  • Fig. 6 Segmental outlook - Type, Thickness, and End Uses
  • Fig. 7 Competitive outlook
  • Fig. 8 Value chain analysis
  • Fig. 9 Market dynamics
  • Fig. 10 Porter's Analysis
  • Fig. 11 PESTEL Analysis
  • Fig. 12 Ready-To-Use Pharmaceutical Packaging Market, by Container Type: Key takeaways
  • Fig. 13 Ready-To-Use Pharmaceutical Packaging Market, by Container Type: Market share, 2024 & 2030
  • Fig. 14 Ready-To-Use Pharmaceutical Packaging Market, by End Use: Key takeaways
  • Fig. 15 Ready-To-Use Pharmaceutical Packaging Market, by End Use: Market share, 2024 & 2030
  • Fig. 16 Ready-To-Use Pharmaceutical Packaging Market, by Region: Key takeaways
  • Fig. 17 Ready-To-Use Pharmaceutical Packaging Market, by Region: Market share, 2024 & 2030
目次
Product Code: GVR-4-68040-579-1

Ready-to-Use Pharmaceutical Packaging Market Growth & Trends:

The global ready-to-use pharmaceutical packaging market size is anticipated to reach USD 15.66 billion by 2030 and is anticipated to expand at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research, Inc. The ready-to-use (RTU) pharmaceutical packaging industry is a critical component of the global healthcare and pharmaceutical supply chain, and it is known for its role in enhancing sterility assurance, operational efficiency, and regulatory compliance. RTU packaging, comprising pre-sterilized vials, syringes, and cartridges, eliminates the need for in-house cleaning and sterilization processes, enabling pharmaceutical manufacturers to streamline aseptic fill-finish operations.

This market serves a broad spectrum of applications, ranging from vaccines and biologics to oncology drugs and emergency injectables. As the pharmaceutical industry evolves to meet the rising global demand for injectable therapies, the RTU format stands out for its ability to reduce contamination risk, accelerate time-to-market, and ensure consistent quality across decentralized manufacturing networks. A major driver behind the RTU pharmaceutical packaging market's expansion is the growing shift toward biologics and high-potency drugs that require stringent sterility and precision in packaging. RTU containers offer pharmaceutical firms significant advantages over traditional packaging formats, such as reduced labor intensity, lower capital investment in sterilization infrastructure, and faster regulatory validation. These benefits are especially valuable in regions with growing biopharmaceutical investments and in CDMO environments where production flexibility is critical.

Furthermore, innovations in packaging materials and container closure systems-such as polymer-based syringes for high-viscosity biologics or advanced barrier-coated glass-are unlocking new applications and reinforcing the RTU market's relevance in a quality-driven, efficiency-focused pharmaceutical landscape. The market players focus on various strategic initiatives such as mergers, acquisitions, and collaborations. For instance, in March 2025, H&T Presspart, a division of Heitkamp & Thumann Group, launched Vytal, an innovative ready-to-use snap-fit closure designed for advanced therapeutics like biologics, monoclonal antibodies, and cell-based therapies.

Ready-to-Use Pharmaceutical Packaging Market Report Highlights:

  • Based on container type, sterile vials held the largest share, accumulating a USD 5.17 billion market size in 2024.
  • Based on end use, glass accounted for the largest market share of 56.12% in 2024.
  • North America dominated the market. Rising demand for outsourced sterile manufacturing among North American biopharma companies fuels RTU packaging adoption, as CDMOs prioritize ready-to-fill formats to optimize throughput. This trend is further reinforced by capacity expansions across aseptic fill-finish operations in the U.S. and Canada.
  • The U.S. was the leading market in North America and captured around 80% of the revenue market share in 2024.
  • Market players operating in the recycling engineering plastics market include Schott AG, Gerresheimer AG, West Pharmaceutical Services, Stevanato Group, SGD Pharma, Nipro Corporation, AptarGroup, Berry Global, and Datwyler.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Types & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Insights
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. Ready-To-Use Pharmaceutical Packaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Raw Material Trends
  • 3.4. Technology Overview
    • 3.4.1. Commercial Production Technology
    • 3.4.2. Roadmap of Technology Advancement, 2018 to 2030
  • 3.5. Impact of Circular Economy
  • 3.6. Regulatory Framework
    • 3.6.1. Policies and Incentive Plans
    • 3.6.2. Standards and Compliances
    • 3.6.3. Regulatory Impact Analysis
  • 3.7. Market Dynamics
    • 3.7.1. Market Driver Analysis
    • 3.7.2. Market Restraint Analysis
    • 3.7.3. Industry Challenges
  • 3.8. Porter's Five Forces Analysis
    • 3.8.1. Supplier Power
    • 3.8.2. Buyer Power
    • 3.8.3. Substitution Threat
    • 3.8.4. Threat from New Entrant
    • 3.8.5. Competitive Rivalry
  • 3.9. PESTEL Analysis
    • 3.9.1. Political Landscape
    • 3.9.2. Economic Landscape
    • 3.9.3. Social Landscape
    • 3.9.4. Technological Landscape
    • 3.9.5. Environmental Landscape
    • 3.9.6. Legal Landscape

Chapter 4. Ready-To-Use Pharmaceutical Packaging Market: Type Outlook Estimates & Forecasts

  • 4.1. Ready-To-Use Pharmaceutical Packaging Market: Type Movement Analysis, 2024 & 2030
    • 4.1.1. Sterile Vials
      • 4.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.2. Sterile Syringes
      • 4.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.3. Sterile Cartridges
      • 4.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Ready-To-Use Pharmaceutical Packaging Market: End Use Outlook Estimates & Forecasts

  • 5.1. Ready-To-Use Pharmaceutical Packaging Market: End Use Movement Analysis, 2024 & 2030
    • 5.1.1. Glass
      • 5.1.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.2. Plastic
      • 5.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.3. Rubber
      • 5.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.1.4. Aluminum
      • 5.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Ready-To-Use Pharmaceutical Packaging Market Regional Outlook Estimates & Forecasts

  • 6.1. Regional Snapshot
  • 6.2. Ready-To-Use Pharmaceutical Packaging Market: Regional Movement Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
    • 6.3.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.3.4. U.S.
      • 6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.3.4.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.3.4.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.3.5. Canada
      • 6.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.3.5.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.3.5.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.3.6. Mexico
      • 6.3.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.3.6.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.3.6.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
    • 6.4.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.4.4. UK
      • 6.4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.4.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.4.4.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.4.5. Germany
      • 6.4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.5.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.4.5.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.4.6. France
      • 6.4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.6.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.4.6.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.4.7. Italy
      • 6.4.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.7.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.4.7.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.4.8. Spain
      • 6.4.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.4.8.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.4.8.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
    • 6.5.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.5.4. China
      • 6.5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.5.4.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.5.4.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.5.5. India
      • 6.5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.5.5.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.5.5.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.5.6. Japan
      • 6.5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.5.6.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.5.6.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.5.7.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.5.7.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.5.8. Australia
      • 6.5.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.5.8.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.5.8.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
    • 6.6.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.6.4. Brazil
      • 6.6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.6.4.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.6.4.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.6.5. Argentina
      • 6.6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.6.5.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.6.5.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • 6.7. Middle East & Africa
    • 6.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
    • 6.7.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.7.4. Saudi Arabia
      • 6.7.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.7.4.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)
    • 6.7.5. South Africa
      • 6.7.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.7.5.2. Market estimates and forecast, by container type, 2018 - 2030 (USD Million)
      • 6.7.5.3. Market estimates and forecast, by end use, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Vendor Landscape
    • 7.2.1. Company categorization
    • 7.2.2. List of Key Distributors and channel Partners
    • 7.2.3. List of Potential Customers/End-users
  • 7.3. Competitive Dynamics
    • 7.3.1. Company Market Share Analysis & Market Positioning
    • 7.3.2. Competitive Benchmarking
    • 7.3.3. Strategy Mapping
    • 7.3.4. Heat Map Analysis
  • 7.4. Company Profiles/Listing
    • 7.4.1. Participant's overview
    • 7.4.2. Financial performance
    • 7.4.3. Product benchmarking
      • 7.4.3.1. Schott AG
      • 7.4.3.2. Gerresheimer AG
      • 7.4.3.3. West Pharmaceutical Services
      • 7.4.3.4. Stevanato Group
      • 7.4.3.5. SGD Pharma
      • 7.4.3.6. Nipro Corporation
      • 7.4.3.7. AptarGroup
      • 7.4.3.8. Berry Global
      • 7.4.3.9. Datwyler